Issue Information
23 July 2019
A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice
Xiaobo Wang, Mark R. Sommerfeld, Kerstin Jahn‐Hofmann, Bishuang Cai, Aveline Filliol, Helen E. Remotti, Robert F. Schwabe, Aimo Kannt, Ira Tabas – 23 July 2019 – Nonalcoholic steatohepatitis (NASH) is emerging as a major public health issue and is associated with significant liver‐related morbidity and mortality. At present, there are no approved drug therapies for NASH.
Peribiliary Gland Niche Participates in Biliary Tree Regeneration in Mouse and in Human Primary Sclerosing Cholangitis
Guido Carpino, Lorenzo Nevi, Diletta Overi, Vincenzo Cardinale, Wei‐Yu Lu, Sabina Di Matteo, Samira Safarikia, Pasquale Bartolomeo Berloco, Rosanna Venere, Paolo Onori, Antonio Franchitto, Stuart J. Forbes, Domenico Alvaro, Eugenio Gaudio – 22 July 2019
Letter to the Editor: mTOR‐Inhibitor‐Based Immunosuppression Following Liver Transplantation for Hereditary Hemorrhagic Telangiectasia
Jose Castellote, José Maria Mora Luján, Antoni Riera‐Mestre – 22 July 2019
Letter to the Editor: Liver Transplantation for Acute Liver Failure Because of Dengue Fever: First Successful Reported Case Worldwide
Narendra S. Choudhary, Sanjiv Saigal, Arvinder S. Soin – 22 July 2019
The Mutational Features of Aristolochic Acid–Induced Mouse and Human Liver Cancers
Zhao‐Ning Lu, Qing Luo, Li‐Nan Zhao, Yi Shi, Na Wang, Lan Wang, Ze‐Guang Han – 20 July 2019
Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis
Yoosoo Chang, Seungho Ryu, Yejin Kim, Yong Kyun Cho, Eunju Sung, Han‐Na Kim, Jiin Ahn, Hyun‐Suk Jung, Kyung Eun Yun, Seolhye Kim, Ki‐Chul Sung, Chong Il Sohn, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne – 19 July 2019
Reply
Mussarat N. Rahim, Michael A. Heneghan – 19 July 2019